Clinical Trial Update: A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healthy Overweight/Obese Participants [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating the safety, tolerability, and pharmacokinetics of LAE103 alone or in combination with LAE102 in healthy overweight/obese participa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• LAE102
• LAE103

Snippet

Sponsor: Laekna Limited | Conditions: Overweight and Obesity | Phase 1 | Status: RECRUITING